9NC (a topoisomerase I inhibitor) in prostate and breast cell lines [48], anti-mitotic agents ENMD-1198 and MKC-1 in prostate cancer cell lines [49], have all been shown to exert their effect through upregulation of RKIP. The gene discussed is PEBP1; the disease is Familial prostate cancer.